Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

263 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
A multicenter, phase II trial of triplet antiemetic therapy with palonosetron, aprepitant, and olanzapine for highly emetogenic chemotherapy in breast cancer (PATROL-II).
Suzuki K, Yokokawa T, Kawaguchi T, Takada S, Tamaki S, Kawasaki Y, Yamaguchi T, Koizumi K, Matsumoto T, Sakata Y, Arakawa Y, Ayuhara H, Hosonaga M, Yamaguchi M, Tsuji D. Suzuki K, et al. Among authors: yokokawa t. Sci Rep. 2024 Nov 16;14(1):28271. doi: 10.1038/s41598-024-79781-6. Sci Rep. 2024. PMID: 39550497 Free PMC article. Clinical Trial.
Very short-term blood pressure variability by pulse transit time-based measurements during night-time predicts future cardiovascular events in patients with ischemic heart disease.
Ogawara R, Misaka T, Ohashi N, Ichimura S, Tomita Y, Tani T, Anzai F, Sato Y, Yokokawa T, Sato A, Shimizu T, Sato T, Oikawa M, Kobayashi A, Yoshihisa A, Takeishi Y. Ogawara R, et al. Among authors: yokokawa t. Clin Res Cardiol. 2024 Sep 16. doi: 10.1007/s00392-024-02539-7. Online ahead of print. Clin Res Cardiol. 2024. PMID: 39297937
Cost of Pegfilgrastim for the Prophylaxis of Chemotherapy-induced Febrile Neutropenia in Patients with Breast Cancer Receiving Perioperative Chemotherapy in Daily Practice in Japan: A Posthoc Analysis in a Single-center Retrospective Study.
Tomomatsu T, Shimizu H, Yokokawa T, Fukada I, Kawakami K, Kobayashi K, Aoyama T, Suzuki W, Sugisaki T, Hashimoto K, Asano M, Mori Y, Hara F, Takano T, Ohno S, Yamaguchi M. Tomomatsu T, et al. Among authors: yokokawa t. Yakugaku Zasshi. 2024;144(9):897-904. doi: 10.1248/yakushi.24-00030. Yakugaku Zasshi. 2024. PMID: 39218657 Free article.
Transcriptional profiling unveils molecular subgroups of adaptive and maladaptive right ventricular remodeling in pulmonary hypertension.
Khassafi F, Chelladurai P, Valasarajan C, Nayakanti SR, Martineau S, Sommer N, Yokokawa T, Boucherat O, Kamal A, Kiely DG, Swift AJ, Alabed S, Omura J, Breuils-Bonnet S, Kuenne C, Potus F, Günther S, Savai R, Seeger W, Looso M, Lawrie A, Zaugg JB, Tello K, Provencher S, Bonnet S, Pullamsetti SS. Khassafi F, et al. Among authors: yokokawa t. Nat Cardiovasc Res. 2023 Oct;2(10):917-936. doi: 10.1038/s44161-023-00338-3. Epub 2023 Sep 28. Nat Cardiovasc Res. 2023. PMID: 39196250 Free PMC article.
Reduced Fetuin-A Levels Are Associated With Exercise Intolerance and Predict the Risk of Adverse Outcomes in Patients With Heart Failure: The Role of Cardiac-Hepatic-Peripheral Interaction.
Tomita Y, Misaka T, Sugawara Y, Ichijo Y, Anzai F, Sato Y, Kimishima Y, Yokokawa T, Sato T, Oikawa M, Kobayashi A, Yoshihisa A, Takeishi Y. Tomita Y, et al. Among authors: yokokawa t. J Am Heart Assoc. 2024 Sep 3;13(17):e035139. doi: 10.1161/JAHA.124.035139. Epub 2024 Aug 27. J Am Heart Assoc. 2024. PMID: 39189483 Free article.
263 results